Deep, qualified next-technology sequencing has disclosed that subclonal mutations (i.e., These present in only a portion of tumor cells) can be detected for all driver genes and they are associated with quick disease progression and inadequate final result.11–13 This is particularly applicable for TP53 Vendor ini tidak hanya membentuk denyut https://stevee085vdk2.blog-a-story.com/profile